Skip to Main Content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

Read & Publish Agreements Negotiated by CAUL

Future Science Group

Future Science Group

Future Science Group (FSG) is a scientific publisher, curating online, print and in-person resources to serve the scientific and medical communities. Future Science has expanded over the years to publish digital/virtual hubs and run events, as well as creative services and publishing solutions.

Journals are housed on two websites: Future Medicine, which comprises the journals covering clinical and translational medicine and the biosciences, and Future Science, which comprises the journals that focus on applied science and intellectual property issues in research and development. 

Participating institutions

  • University of Melbourne

From 2022, the following institutions will also participate in this agreement:

  • Australian National University
  • Deakin University
  • Monash University
  • University of Adelaide
  • University of New South Wales
  • University of Queensland

Authors who do not see their institution listed above should contact library staff to enquire further.

Included titles

  • Bioanalysis
  • Biomarkers in Medicine
  • Epigenomics
  • Future Cardiology
  • Future Medicinal Chemistry
  • Future Microbiology
  • Future Oncology
  • Future Virology
  • Immunotherapy
  • Journal of 3D Printing in Medicine
  • Journal of Comparative Effectiveness Research
  • Nanomedicine
  • Neurodegenerative Disease Management
  • Pain Management
  • Personalized Medicine
  • Pharmaceutical Patent Analyst
  • Pharmacogenomics
  • Regenerative Medicine
  • Therapeutic Delivery

Please note: This agreement does not include Future Science Group Gold OA journals.

Information for authors

Corresponding authors from institutions listed under 'Participating institutions' may publish immediately to open access on the publisher's platform once the article has been accepted, with no transactional APCs. APC-free open access publishing excludes Drug Evaluation articles and content or research that is sponsored or funded by pharmaceutical or biotechnology companies.

You will be recognised as being eligible for open access publishing with no transactional APCs via your institutional email address.

Author rights

Articles from authors at member institutions will be published under a CC-BY license, which allows maximum reuse while protecting the authors' rights of acknowledgment as authors.

How to submit your article for open access publishing

Submit your article via the following links to the publisher's submission system:

Information on publishing in these titles is available at the following links:

Information for libraries

This Read and Publish Agreement is a single year agreement (2021 or 2022). 

Licensing information 

Licensing is as per CAUL’s pre-approved license template included in the Fast Track to Open Access Toolkit.


Read access for the 19 journals extends back to 1 January 2018. Access includes post termination access to the 19 journals for the year subscribed.


  • The agreement provides open access publishing in the journals listed under 'Included titles' by corresponding authors of institutions listed under 'Participating institutions'. 
  • There is no limit on the number of articles that can be published under the agreement.
  • There are no transactional APCs for papers submitted by corresponding authors from participating institutions.

Please contact the designated Content Coordinator at your library if you wish to know more about this agreement.

Publishing alerts

No publishing alerts are provided. However, library staff can register to receive publishing alerts when an article is published by an author at their institution. Visit the Future Medicine and Future Science websites for further information.

Sharing via repositories

Green open access
  • Green open access is allowed with no embargo. 
  • There is no automated loading to institutional repositories.
Other repositories